{"nctId":"NCT00132808","briefTitle":"Zoledronic Acid in the Prevention of Bone Loss in Postmenopausal Women With Osteopenia, 45 Years of Age and Older","startDateStruct":{"date":"2004-07"},"conditions":["Osteopenia"],"count":581,"armGroups":[{"label":"Zoledronic Acid 2x5 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Zoledronic Acid"]},{"label":"Zoledronic Acid 1x5 mg","type":"EXPERIMENTAL","interventionNames":["Drug: Zoledronic Acid","Drug: Placebo"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Zoledronic Acid","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Postmenopausal\n* Greater than or equal to 45 years of age\n* Osteopenia (lumbar spine bone mineral density \\[BMD\\] T-score between -1.0 and -2.5, and BMD T-score \\> -2.5 at the femoral neck)\n\nExclusion Criteria:\n\n* Patients with more than one Grade 1 vertebral fracture (as per Genant method; patients with one Grade 1 vertebral fracture are eligible to participate)\n* Patients with any Grade 2 or 3 vertebral fracture (as per Genant method)\n* Patients with 25-(OH) vitamin D levels less than 15 ng/mL prior to randomization\n\nOther protocol-defined inclusion/exclusion criteria may apply.","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"45 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percentage Change in Lumbar Spine Bone Mineral Density (BMD) at Month 24 Relative to Baseline, by Stratum","description":"The percentage change in lumbar spine BMD at Month 24 relative to baseline was derived as 100 x (lumbar spine BMD at 24 Month - lumbar spine BMD at baseline) / (lumbar spine BMD at baseline).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.62","spread":"0.444"},{"groupId":"OG001","value":"4.03","spread":"0.444"},{"groupId":"OG002","value":"-2.24","spread":"0.428"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.60","spread":"0.343"},{"groupId":"OG001","value":"4.76","spread":"0.356"},{"groupId":"OG002","value":"-0.65","spread":"0.339"}]}]}]},{"type":"SECONDARY","title":"Percentage Change in Total Hip BMD at Month 24 Relative to Baseline, by Stratum.","description":"The percentage change in total hip BMD at Month 24 relative to baseline was derived as 100 x (total hip BMD at 24 Month - total hip BMD at baseline) / (total hip BMD at baseline).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.66","spread":"0.318"},{"groupId":"OG001","value":"2.55","spread":"0.317"},{"groupId":"OG002","value":"-2.10","spread":"0.293"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.04","spread":"0.265"},{"groupId":"OG001","value":"2.11","spread":"0.282"},{"groupId":"OG002","value":"-1.04","spread":"0.265"}]}]}]},{"type":"SECONDARY","title":"Percentage Change in Femoral Neck BMD at Month 24 Relative to Baseline, by Stratum.","description":"The percentage change in femoral neck BMD at Month 24 relative to baseline was derived as 100 x (femoral neck BMD at 24 Month - femoral neck BMD at baseline) / (femoral neck BMD at baseline).","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.04","spread":"0.550"},{"groupId":"OG001","value":"2.01","spread":"0.549"},{"groupId":"OG002","value":"-1.55","spread":"0.508"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.35","spread":"0.344"},{"groupId":"OG001","value":"1.46","spread":"0.366"},{"groupId":"OG002","value":"-1.18","spread":"0.343"}]}]}]},{"type":"SECONDARY","title":"Biochemical Marker of Bone Resorption: Serum Beta C-telopeptides (b-CTx), by Stratum","description":"Biomarker: Serum b-CTx levels at Months 6, 12, 18 and 24 by stratum.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2217","spread":"0.11791"},{"groupId":"OG001","value":"0.2286","spread":"0.09630"},{"groupId":"OG002","value":"0.6439","spread":"0.27902"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2861","spread":"0.13776"},{"groupId":"OG001","value":"0.3111","spread":"0.13195"},{"groupId":"OG002","value":"0.6634","spread":"0.25433"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2187","spread":"0.16812"},{"groupId":"OG001","value":"0.3605","spread":"0.14847"},{"groupId":"OG002","value":"0.6444","spread":"0.28254"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2864","spread":"0.12242"},{"groupId":"OG001","value":"0.3777","spread":"0.14943"},{"groupId":"OG002","value":"0.6640","spread":"0.27538"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1918","spread":"0.12648"},{"groupId":"OG001","value":"0.1888","spread":"0.10625"},{"groupId":"OG002","value":"0.5802","spread":"0.25034"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2696","spread":"0.18247"},{"groupId":"OG001","value":"0.2484","spread":"0.11435"},{"groupId":"OG002","value":"0.5634","spread":"0.23442"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.1986","spread":"0.14900"},{"groupId":"OG001","value":"0.2854","spread":"0.14391"},{"groupId":"OG002","value":"0.5742","spread":"0.24399"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"0.2554","spread":"0.17049"},{"groupId":"OG001","value":"0.3254","spread":"0.15260"},{"groupId":"OG002","value":"0.6012","spread":"0.26942"}]}]}]},{"type":"SECONDARY","title":"Biochemical Marker of Bone Formation: Serum N-terminal Propeptide of Type 1 Collagen (P1NP), by Stratum","description":"Biomarker: Serum P1NP levels at Months 6, 12, 18 and 24 by stratum.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20.851","spread":"9.7724"},{"groupId":"OG001","value":"20.752","spread":"9.7560"},{"groupId":"OG002","value":"59.449","spread":"20.3291"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.231","spread":"12.3748"},{"groupId":"OG001","value":"30.500","spread":"14.8217"},{"groupId":"OG002","value":"55.166","spread":"20.5274"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.102","spread":"12.6635"},{"groupId":"OG001","value":"35.561","spread":"14.1588"},{"groupId":"OG002","value":"55.775","spread":"19.8842"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.288","spread":"12.2706"},{"groupId":"OG001","value":"38.743","spread":"14.7626"},{"groupId":"OG002","value":"56.315","spread":"20.3715"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.369","spread":"14.1819"},{"groupId":"OG001","value":"19.423","spread":"16.6028"},{"groupId":"OG002","value":"50.271","spread":"22.6624"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.333","spread":"15.8193"},{"groupId":"OG001","value":"26.363","spread":"13.1112"},{"groupId":"OG002","value":"49.581","spread":"20.6559"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.031","spread":"14.8270"},{"groupId":"OG001","value":"29.569","spread":"14.7631"},{"groupId":"OG002","value":"46.943","spread":"18.8147"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"26.211","spread":"11.8566"},{"groupId":"OG001","value":"34.418","spread":"15.4474"},{"groupId":"OG002","value":"51.621","spread":"20.9281"}]}]}]},{"type":"SECONDARY","title":"Biochemical Marker of Bone Formation: Bone Serum Alkaline Phosphatase (BSAP), by Stratum","description":"Biomarker: BSAP levels at Months 6, 12, 18 and 24 by stratum.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.718","spread":"2.5827"},{"groupId":"OG001","value":"8.841","spread":"2.2434"},{"groupId":"OG002","value":"13.982","spread":"4.7106"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.945","spread":"2.9027"},{"groupId":"OG001","value":"10.539","spread":"2.9800"},{"groupId":"OG002","value":"14.127","spread":"4.8981"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.365","spread":"2.5574"},{"groupId":"OG001","value":"11.233","spread":"3.1563"},{"groupId":"OG002","value":"14.149","spread":"4.8878"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.799","spread":"2.5836"},{"groupId":"OG001","value":"11.764","spread":"3.8401"},{"groupId":"OG002","value":"14.353","spread":"4.9089"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.219","spread":"2.8126"},{"groupId":"OG001","value":"7.925","spread":"2.2847"},{"groupId":"OG002","value":"13.394","spread":"5.2169"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.678","spread":"3.0216"},{"groupId":"OG001","value":"9.139","spread":"2.4558"},{"groupId":"OG002","value":"13.650","spread":"4.8295"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.357","spread":"2.2152"},{"groupId":"OG001","value":"10.023","spread":"2.8237"},{"groupId":"OG002","value":"13.222","spread":"4.9167"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"9.730","spread":"2.7591"},{"groupId":"OG001","value":"10.916","spread":"3.5878"},{"groupId":"OG002","value":"13.902","spread":"4.6302"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":21,"n":198},"commonTop":["Arthralgia","Myalgia","Pyrexia","Back pain","Headache"]}}}